Cargando…
Antiviral Treatments
Most viral respiratory tract infections are caused by classic respiratory viruses, including influenza, respiratory syncytial virus, human metapneumovirus, parainfluenza, rhinovirus, and adenovirus, whereas other viruses, such as herpes simplex, cytomegalovirus, and measles virus, can opportunistica...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131036/ https://www.ncbi.nlm.nih.gov/pubmed/28159156 http://dx.doi.org/10.1016/j.ccm.2016.11.008 |
_version_ | 1783517146409598976 |
---|---|
author | Ison, Michael G. |
author_facet | Ison, Michael G. |
author_sort | Ison, Michael G. |
collection | PubMed |
description | Most viral respiratory tract infections are caused by classic respiratory viruses, including influenza, respiratory syncytial virus, human metapneumovirus, parainfluenza, rhinovirus, and adenovirus, whereas other viruses, such as herpes simplex, cytomegalovirus, and measles virus, can opportunistically affect the respiratory tract. The M2 inhibitors, amantadine and rimantadine, were historically effective for the prevention and treatment of influenza A but all circulating strains are currently resistant to these drugs. Neuraminidase inhibitors are the sole approved class of antivirals to treat influenza. Ribavirin, especially when combined with intravenous antibody, reduces morbidity and mortality among immunosuppressed patients. |
format | Online Article Text |
id | pubmed-7131036 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71310362020-04-08 Antiviral Treatments Ison, Michael G. Clin Chest Med Article Most viral respiratory tract infections are caused by classic respiratory viruses, including influenza, respiratory syncytial virus, human metapneumovirus, parainfluenza, rhinovirus, and adenovirus, whereas other viruses, such as herpes simplex, cytomegalovirus, and measles virus, can opportunistically affect the respiratory tract. The M2 inhibitors, amantadine and rimantadine, were historically effective for the prevention and treatment of influenza A but all circulating strains are currently resistant to these drugs. Neuraminidase inhibitors are the sole approved class of antivirals to treat influenza. Ribavirin, especially when combined with intravenous antibody, reduces morbidity and mortality among immunosuppressed patients. Elsevier Inc. 2017-03 2016-12-13 /pmc/articles/PMC7131036/ /pubmed/28159156 http://dx.doi.org/10.1016/j.ccm.2016.11.008 Text en © 2016 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Ison, Michael G. Antiviral Treatments |
title | Antiviral Treatments |
title_full | Antiviral Treatments |
title_fullStr | Antiviral Treatments |
title_full_unstemmed | Antiviral Treatments |
title_short | Antiviral Treatments |
title_sort | antiviral treatments |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131036/ https://www.ncbi.nlm.nih.gov/pubmed/28159156 http://dx.doi.org/10.1016/j.ccm.2016.11.008 |
work_keys_str_mv | AT isonmichaelg antiviraltreatments |